中東およびアフリカの2030年までの乳がん治療薬市場予測 - 地域分析 - 薬物療法別 [標的薬物療法 (アベマシクリブ、Ado-トラスツズマブ エムタンシン、パルボシクリブ、トラスツズマブ、およびその他の標的薬物療法)、ホルモン薬物療法 (選択的エストロゲン受容体調節物質、 「アロマターゼ阻害剤、選択的エストロゲン受容体ダウンレギュレーター)、化学療法、免疫療法/生物学的療法」、乳がんの種類(ホルモン受容体、HER2+、トリプルネガティブ乳がん)、流通チャネル(病院の薬局、ドラッグストア、小売薬局、オンライン薬局)
増大する乳がんの負担が中東およびアフリカの乳がん治療市場を促進
乳がんは最も一般的ながんと考えられていますがんは世界中の女性の間で発生しており、その発生率は世界的に増加しています。ライフスタイルの変化、ホルモンの不均衡、遺伝的素因、環境要因などの要因が乳がんの罹患率上昇に寄与しています。 WHO によると、2020 年には世界中で 68 万 5,000 人が乳がんで死亡し、そのうち 230 万人が新たに乳がんと診断されました。乳がんは世界で最も一般的ながんの 1 つであり、2020 年末現在、過去 5 年以内に診断を受けた 780 万人の女性が生存しています。乳がんは世界中で、思春期以降のあらゆる年齢の女性に影響を与えます。しかし、その有病率は年齢とともに増加します。乳がん症例の増加に伴い、患者の転帰を改善するための効果的な標的療法の必要性が高まっています。これにより、乳がん治療薬の研究開発活動が急増しています。したがって、乳がんの負担の増大が中東およびアフリカの乳がん治療市場を推進しています。
中東およびアフリカの乳がん治療薬市場の概要
中東およびアフリカの乳がん治療薬市場は、UAE、サウジアラビア、南アフリカ、およびその他の中東地域に分割されています。 &アフリカ。医療インフラの変化と政府と国際関係者の官民パートナーシップにより、この国の医療セクターは強化されています。これらのパートナーシップと民営化の取り組みは、国家経済を変革するためのサウジ政府の「ビジョン2030」戦略に含まれる政策と一致している。国際貿易局によると、サウジアラビア政府はビジョン2030の一環として、同国の医療インフラの構築に約650億ドルを投資した。さらに、2030年までに民間部門の貢献を40%から65%に増やす予定である。 290の病院と2,300の一次医療センターの民営化に焦点を当てる。インフラストラクチャとイノベーションへの投資の増加により、市場の成長が促進されると予想されます。
2023年6月、MSD GCCはアブダビ保健省(DoH)との腫瘍学研究パートナーシップを拡大しました。 2023年のBIO国際大会で署名されたこの契約は、両社間の長期的な協力関係の継続を意味するものでした。新たなパートナーシップの枠組みの中で、両社は協力して、非小細胞肺がんとトリプルネガティブ乳がんに焦点を当てた腫瘍学の分野で2つの観察研究研究を開始する予定です。この研究は、これらの疾患に関連する医療上の課題に対処し、患者の転帰を改善する能力を向上させることを目的としています。したがって、国内での新しく革新的な製品の認識と開発を広めるための企業の取り組みの拡大は、UAEの乳がん治療薬市場の成長に大きく貢献しています。
2021年10月、クウェート国立銀行(NBK)は乳がん啓発月間に女性の健康を促進する年次キャンペーンを開始しました。このキャンペーンは、乳がんに関する社会的意識を高め、その予防方法を促進するために銀行が継続しているキャンペーンの一環です。したがって、上記の要因は乳がん治療薬市場の成長を大きく促進します。
中東およびアフリカの乳がん治療薬市場の収益と2030年までの予測 (百万米ドル)
中東およびアフリカの乳がん治療薬市場のセグメント化
中東およびアフリカ乳がん治療薬市場は、薬物療法、乳がんの種類、流通チャネルに基づいて分割されています。
中東およびアフリカの乳がん治療市場は、薬物療法に基づいて、標的薬物療法、ホルモン薬物療法、化学療法、免疫療法/生物学的療法に分割されています。分子標的薬治療セグメントは、2022年にはより大きなシェアを保持しました。分子標的薬治療セグメントは、2022年にはより大きなシェアを保持しました。分子標的薬治療セグメントは、アベマシクリブ、アドトラスツズマブ エムタンシン、パルボシクリブ、トラスツズマブ、およびその他の標的薬物療法にさらにサブセグメント化されています。さらに、ホルモン薬物療法セグメントは、選択的エストロゲン受容体モジュレーター、アロマターゼ阻害剤、選択的エストロゲン受容体ダウンレギュレーターに分類されます。
乳がんの種類に関して、中東およびアフリカの乳がん治療薬市場は、ホルモン受容体、HER2+、およびトリプルネガティブ乳がんに分類されます。 2022 年には、ホルモン受容体セグメントがより大きなシェアを占めました。
中東およびアフリカの乳がん治療薬市場は、流通チャネルごとに、病院薬局、ドラッグストアおよび小売薬局、オンライン薬局に分割されています。 2022 年には病院薬局セグメントがより大きなシェアを占めました。
中東およびアフリカの乳がん治療薬市場は、国ごとに南アフリカ、サウジアラビア、UAE、およびその他の中東およびアフリカに分類されます。サウジアラビアは、2022 年の中東およびアフリカの乳がん治療薬市場を独占しました。
イーライリリー社、エーザイ株式会社、ノバルティス AG、アストラゼネカ Plc、ファイザー社、ギリアド サイエンシズ社、メルク社、テバ ファーマシューティカル社Industries Ltd および Amgen Inc は、中東およびアフリカの乳がん治療市場で事業を展開する大手企業の一部です。
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Breast Cancer Therapeutics Market - Key Industry Dynamics
4.1 Key Market Drivers
4.1.1 Growing Burden of Breast Cancer
4.1.2 Launch of Several Diagnostics and Screening Programs
4.2 Key Market Restraints
4.2.1 High Cost of Diagnosis and Treatment
4.3 Key Market Opportunities
4.3.1 Increased Support from Government and Private Organizations
4.4 Key Future Trends
4.4.1 Increasing Use of Personalized Medicine
4.5 Impact Analysis:
5. Breast Cancer Therapeutics Market - Middle East & Africa Market Analysis
5.1 Middle East & Africa Breast Cancer Therapeutics Market Revenue (US$ Mn), 2022 - 2030
6. Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 - by Drug Therapy
6.1 Overview
6.2 Middle East & Africa Breast Cancer Therapeutics Market Revenue Share, by Drug Therapy, 2022 & 2030 (%)
6.3 Targeted Drug Therapy
6.3.1 Overview
6.3.2 Targeted Drug Therapy: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
6.3.2.1 Middle East & Africa Breast Cancer Therapeutics Market, by Targeted Drug Therapy, 2020-2030 (US$ Million)
6.4 Hormonal Drug Therapy
6.4.1 Overview
6.4.2 Hormonal Drug Therapy: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
6.4.2.1 Middle East & Africa Breast Cancer Therapeutics Market, by Hormonal Drug Therapy, 2020-2030 (US$ Million)
6.5 Chemotherapy
6.5.1 Overview
6.5.2 Chemotherapy: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Immunotherapy/ Biological Therapy
6.6.1 Overview
6.6.2 Immunotherapy/ Biological Therapy: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 - by Breast Cancer Type
7.1 Overview
7.2 Middle East & Africa Breast Cancer Therapeutics Market Revenue Share, by Breast Cancer Type, 2022 & 2030 (%)
7.3 Hormone Receptor
7.3.1 Overview
7.3.2 Hormone Receptor: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
7.4 HER2+ (human epidermal growth factor receptor 2)
7.4.1 Overview
7.4.2 HER2+: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Triple-Negative Breast Cancer
7.5.1 Overview
7.5.2 Triple-Negative Breast Cancer: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 - by Distribution Channel
8.1 Overview
8.2 Middle East & Africa Breast Cancer Therapeutics Market Revenue Share, by Distribution Channel, 2022 & 2030 (%)
8.3 Hospital Pharmacies
8.3.1 Overview
8.3.2 Hospital Pharmacies: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Drug Store and Retail Pharmacies
8.4.1 Overview
8.4.2 Drug Store and Retail Pharmacies: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Online Pharmacies
8.5.1 Overview
8.5.2 Online Pharmacies: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Breast Cancer Therapeutics Market -Country Analysis
9.1 Middle East & Africa Breast Cancer Therapeutics Market, Revenue and Forecast to 2030
9.1.1 Overview
9.1.2 Middle East & Africa Breast Cancer Therapeutics Market, Breakdown, by Country- Revenue (2022) (US$ Million)
9.1.3 Middle East & Africa Breast Cancer Therapeutics Market, by Countries, 2022 and 2030 (%)
9.1.3.1 Saudi Arabia
9.1.3.1.1 Saudi Arabia Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
9.1.3.1.2 Saudi Arabia: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.1.2.1 Saudi Arabia: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.1.2.2 Saudi Arabia: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.1.3 Saudi Arabia: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)
9.1.3.1.4 Saudi Arabia: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.3.2 UAE
9.1.3.2.1 UAE Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
9.1.3.2.2 UAE: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.2.2.1 UAE: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.2.2.2 UAE: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.2.3 UAE: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)
9.1.3.2.4 UAE: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.3.3 South Africa
9.1.3.3.1 South Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
9.1.3.3.2 South Africa: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.3.2.1 South Africa: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.3.2.2 South Africa: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.3.3 South Africa: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)
9.1.3.3.4 South Africa: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.3.4 Rest of Middle East & Africa
9.1.3.4.1 Rest of Middle East & Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
9.1.3.4.2 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.4.2.1 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.4.2.2 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.4.3 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)
9.1.3.4.4 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)
10. Breast Cancer Therapeutics Market-Industry Landscape
10.1 Overview
10.2 Growth Strategies in Breast Cancer Therapeutics Market
10.3 Organic Growth Strategies
10.3.1 Overview
10.4 Inorganic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Eli Lilly and Co
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Eisai Co Ltd
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Novartis AG
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 AstraZeneca Plc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Pfizer Inc
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Gilead Sciences Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Merck & Co Inc
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Teva Pharmaceutical Industries Ltd
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Amgen Inc
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms
List of Tables
Table 1. Middle East & Africa Breast Cancer Therapeutics Market Segmentation
Table 2. Middle East & Africa Breast Cancer Therapeutics Market, by Targeted Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 3. Middle East & Africa Breast Cancer Therapeutics Market, by Hormonal Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 4. Saudi Arabia Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 5. Saudi Arabia Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 6. Saudi Arabia Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 7. Saudi Arabia Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)
Table 8. Saudi Arabia Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 9. UAE Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 10. UAE Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 11. UAE Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 12. UAE Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)
Table 13. UAE Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 14. South Africa Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 15. South Africa Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 16. South Africa Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 17. South Africa Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)
Table 18. South Africa Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 19. Rest of Middle East & Africa Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 20. Rest of Middle East & Africa Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 21. Rest of Middle East & Africa Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 22. Rest of Middle East & Africa Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Middle East & Africa Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 24. Recent Organic Growth Strategies in Breast Cancer Therapeutics Market
Table 25. Recent Inorganic Growth Strategies in the Breast Cancer Therapeutics Market
Table 26. Glossary of Terms, Breast Cancer Therapeutics Market
List of Figures
Figure 1. Middle East & Africa Breast Cancer Therapeutics Market Segmentation, By Country
Figure 2. Middle East & Africa Breast Cancer Therapeutics Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Middle East & Africa Breast Cancer Therapeutics Market Revenue (US$ Mn), 2022 - 2030
Figure 5. Middle East & Africa Breast Cancer Therapeutics Market Revenue Share, by Drug Therapy, 2022 & 2030 (%)
Figure 6. Targeted Drug Therapy: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Hormonal Drug Therapy: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Chemotherapy: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Immunotherapy/ Biological Therapy: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Middle East & Africa Breast Cancer Therapeutics Market Revenue Share, by Breast Cancer Type, 2022 & 2030 (%)
Figure 11. Hormone Receptor: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. HER2+: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Triple-Negative Breast Cancer: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Middle East & Africa Breast Cancer Therapeutics Market Revenue Share, by Distribution Channel, 2022 & 2030 (%)
Figure 15. Hospital Pharmacies: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Drug Store and Retail Pharmacies: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Online Pharmacies: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Middle East & Africa Breast Cancer Therapeutics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 19. Middle East & Africa Breast Cancer Therapeutics Market, By Key Countries, 2022 and 2030 (%)
Figure 20. Saudi Arabia Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 21. UAE Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 22. South Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. Rest of Middle East & Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. Growth Strategies in Breast Cancer Therapeutics Market
1. Eli Lilly and Co
2. Eisai Co Ltd
3. Novartis AG
4. AstraZeneca Plc
5. Pfizer Inc
6. Gilead Sciences Inc
7. Merck & Co Inc
8. Teva Pharmaceutical Industries Ltd
9. Amgen Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa breast cancer therapeutics market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa breast cancer therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution